In our study, patients with II genotype have two times higher risk for vascular access failure, but both results did not reach statistical significance.
← all excerpts
Impact of Angiotensin-converting Enzyme and Matrix Metalloproteinase-3 Gene Polymorphisms on Risk for Developing Vascular Access Failure in Hemodialysis Patients - A Pilot Study.
1
—
—